InsiderClue
Stocks · Health care · Pharmaceutical Preparations

HERON THERAPEUTICS, INC. /DE/

HRTX Clue Score36
United States Fiscal year ends December CIK 0000818033
$0.42 +2.34% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.42 −96.01% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.3Operating income−170.9Net income−173.1Fiscal year 2017Revenue30.8 +2,305.6%Operating income−194.6Net income−197.5Fiscal year 2018Revenue77.5 +151.8%Operating income−183.9Net income−178.8Fiscal year 2019Revenue146.0 +88.4%Operating income−210.7Net income−204.7Fiscal year 2020Revenue88.6 −39.3%Operating income−228.2Net income−227.3Fiscal year 2021Revenue86.3 −2.6%Operating income−217.8Net income−220.7EPS, diluted−2.24Fiscal year 2022Revenue107.7 +24.7%Operating income−174.7Net income−182.0EPS, diluted−1.67Fiscal year 2023Revenue127.0 +18.0%Operating income−110.6Net income−110.6EPS, diluted−0.80Fiscal year 2024Revenue144.3 +13.6%Operating income−11.5Net income−13.6EPS, diluted−0.09Fiscal year 2025Revenue154.9 +7.4%Operating income−2.5Net income−20.2EPS, diluted−0.12
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.3 30.8 77.5 146.0 88.6 86.3 107.7 127.0 144.3 154.9
Growth +2,305.6% +151.8% +88.4% −39.3% −2.6% +24.7% +18.0% +13.6% +7.4%
Operating income −170.9 −194.6 −183.9 −210.7 −228.2 −217.8 −174.7 −110.6 −11.5 −2.5
Net income −173.1 −197.5 −178.8 −204.7 −227.3 −220.7 −182.0 −110.6 −13.6 −20.2
Growth
EPS, diluted n/a n/a n/a n/a n/a −2.24 −1.67 −0.80 −0.09 −0.12

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Operating margin−13,363.2%Net margin−13,537.4%Free cash flow margin−10,729.6%Fiscal year 2017Operating margin−632.4%Net margin−641.9%Free cash flow margin−561.8%Fiscal year 2018Operating margin−237.4%Net margin−230.8%Free cash flow margin−259.4%Fiscal year 2019Operating margin−144.3%Net margin−140.3%Free cash flow margin−90.2%Fiscal year 2020Operating margin−257.4%Net margin−256.4%Free cash flow margin−216.2%Fiscal year 2021Operating margin−252.3%Net margin−255.6%Free cash flow margin−239.0%Fiscal year 2022Gross margin49.0%Operating margin−162.2%Net margin−169.1%Free cash flow margin−138.1%Fiscal year 2023Gross margin48.8%Operating margin−87.1%Net margin−87.0%Free cash flow margin−47.5%Fiscal year 2024Gross margin73.2%Operating margin−8.0%Net margin−9.4%Free cash flow margin−16.8%Fiscal year 2025Gross margin73.3%Operating margin−1.6%Net margin−13.0%Free cash flow margin−18.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a 49.0% 48.8% 73.2% 73.3%
Operating margin −13,363.2% −632.4% −237.4% −144.3% −257.4% −252.3% −162.2% −87.1% −8.0% −1.6%
Net margin −13,537.4% −641.9% −230.8% −140.3% −256.4% −255.6% −169.1% −87.0% −9.4% −13.0%
Free cash flow margin −10,729.6% −561.8% −259.4% −90.2% −216.2% −239.0% −138.1% −47.5% −16.8% −18.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−134.1Capital expenditure−3.1Free cash flow−137.2Fiscal year 2017Operating cash flow−170.3Capital expenditure−2.6Free cash flow−172.9Fiscal year 2018Operating cash flow−191.8Capital expenditure−9.2Free cash flow−201.0Fiscal year 2019Operating cash flow−124.6Capital expenditure−7.2Free cash flow−131.7Fiscal year 2020Operating cash flow−184.8Capital expenditure−6.8Free cash flow−191.6Fiscal year 2021Operating cash flow−203.4Capital expenditure−3.0Free cash flow−206.4Fiscal year 2022Operating cash flow−146.9Capital expenditure−1.8Free cash flow−148.7Fiscal year 2023Operating cash flow−58.8Capital expenditure−1.5Free cash flow−60.3Fiscal year 2024Operating cash flow−22.5Capital expenditure−1.7Free cash flow−24.2Fiscal year 2025Operating cash flow−27.6Capital expenditure−0.3Free cash flow−27.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −134.1 −170.3 −191.8 −124.6 −184.8 −203.4 −146.9 −58.8 −22.5 −27.6
Capital expenditure −3.1 −2.6 −9.2 −7.2 −6.8 −3.0 −1.8 −1.5 −1.7 −0.3
Free cash flow −137.2 −172.9 −201.0 −131.7 −191.6 −206.4 −148.7 −60.3 −24.2 −27.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash13.4Shareholders’ equity−21.3Fiscal year 2017Cash144.6Shareholders’ equity131.1Fiscal year 2018Cash31.8Shareholders’ equity370.2Fiscal year 2019Cash71.9Shareholders’ equity403.8Fiscal year 2020Cash105.1Shareholders’ equity236.5Fiscal year 2021Cash90.5Shareholders’ equity77.6Fiscal year 2022Cash15.4Shareholders’ equity13.6Fiscal year 2023Cash28.7Shareholders’ equity−34.0Fiscal year 2024Cash25.8Shareholders’ equity−33.7Fiscal year 2025Cash28.6Shareholders’ equity14.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 13.4 144.6 31.8 71.9 105.1 90.5 15.4 28.7 25.8 28.6
Shareholders’ equity −21.3 131.1 370.2 403.8 236.5 77.6 13.6 −34.0 −33.7 14.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a n/a n/a n/a 49.0% 48.8% 73.2% 73.3%
−13,363.2% −632.4% −237.4% −144.3% −257.4% −252.3% −162.2% −87.1% −8.0% −1.6%
−13,537.4% −641.9% −230.8% −140.3% −256.4% −255.6% −169.1% −87.0% −9.4% −13.0%
−10,729.6% −561.8% −259.4% −90.2% −216.2% −239.0% −138.1% −47.5% −16.8% −18.0%
Spending
8,062.9% 450.4% 180.7% 114.7% 196.9% 151.5% 76.8% 30.8% 11.6% 8.0%
1,670.5% 83.1% 37.8% 26.0% 47.6% 46.5% 57.8% 51.8% 37.0% 35.3%
245.1% 8.3% 11.8% 4.9% 7.7% 3.5% 1.7% 1.2% 1.2% 0.2%
Returns
n/a −150.6% −48.3% −50.7% −96.1% −284.5% −1,341.2% n/a n/a −140.9%
−256.6% −84.3% −38.7% −39.9% −64.3% −72.2% −72.5% −49.7% −5.8% −7.9%
Balance and payout
131.5% 44.0% 19.9% 21.2% 33.1% 74.6% 94.6% 115.3% 114.4% 94.4%